Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection.

Lu F, Liang Q, Abi-Mosleh L, Das A, De Brabander JK, Goldstein JL, Brown MS. · 2015

Read Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. by Lu F, Liang Q, Abi-Mosleh L, Das A, De Brabander JK, Goldstein JL, Brown MS. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4718804.txt.

Description

Feiran Lu, Qiren Liang, Lina Abi-Mosleh, and five colleagues identified the target of a cholesterol-blocking compound in eLife in 2015. NPC1 is a lysosome protein that exports cholesterol arriving from LDL particles, and it is also the doorway Ebola virus uses to enter cells. A compound called U18666A blocks the export at tiny doses, but its exact target was unproven. The team built a light-activated version that locks onto whatever it touches.

In hamster cells, the probe latched onto NPC1, and only active blocker versions competed for the grip. A single mutation in NPC1's sterol-sensing region stopped the binding, while a mutation in its cholesterol-gripping end did not. So the drug's site sits in the sensing region, apart from where cholesterol binds. Since blocking Ebola needs far higher doses, that doorway likely works another way, a clue for cholesterol disease and antiviral design alike.

Catalog record

CREATORLu F, Liang Q, Abi-Mosleh L, Das A, De Brabander JK, Goldstein JL, Brown MS.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4718804

Browse the full library · About the Tower of Babel